A leading group of U.S. tummy doctors wants Americans to get used to talking about their bowel symptoms, at least with their physicians. People are hesitant to discuss digestive trouble with a medical professional, with one in three saying they would mention it only if their doctor brought it up first, according to the American… read on > read on >
All Food:
Minority Patients Less Likely to Get Newer Alzheimer’s Meds
While certain minority groups are more likely to be diagnosed with dementia than their white counterparts, they may also be less likely to be eligible for new disease-slowing treatments, a new study finds. Cognitive, or mental, impairment in Black, Hispanic and Asian patients is more likely to be caused by forms of dementia unrelated to… read on > read on >
Listeria Outbreak Tied to Soft Cheeses Sold at Albertsons, Whole Foods
U.S. health officials have warned that numerous brands of brie and camembert cheese may contain Listeria, a potentially dangerous bacteria. Old Europe Cheese Inc. has recalled more than 20 brands of cheese from retail and wholesale stores nationwide and in Mexico after six people in six states were infected with a specific strain of Listeria.… read on > read on >
Vitamin Supplements May Help People With Cystic Fibrosis
More than 160,000 people around the world have cystic fibrosis, and supplementing with vitamins C and E could help reduce the damaging inflammation in their lungs, according to new research. “Cystic fibrosis is a genetic disease that is associated with increased inflammation, and like many inflammatory diseases, it comes with a large amount of oxidative… read on > read on >
FDA Approves New ALS Drug Despite Uncertain Data
FRIDAY, Sept. 30, 2022 (HealthDay News) – The U.S. Food and Drug Administration on Thursday gave its approval to a new drug for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease. But approval of the drug, called Relyvrio, is bound to stir new questions, with some doubting the strength of data supporting its… read on > read on >
Could a Folic Acid Prescription Help Prevent Suicide?
More than 1 million Americans attempted suicide in 2020, and a new study is hinting at a potential way to reduce that risk: prescription folic acid. The study, of more than 800,000 Americans in a health care database, found that when people were on prescription folic acid, their likelihood of being treated for self-harm or… read on > read on >
More Americans With Heart Disease Are Also Becoming ‘Food Insecure’
Many Americans with heart disease also have limited access to food, and this dangerous combination is growing rapidly, a new study finds. “Food insecurity is a common problem among people with cardiovascular disease, and we are seeing that issue become even more prevalent in recent years,” said lead author Dr. Eric Brandt. He’s a cardiologist… read on > read on >
Healthy Living Boosts Life Span, Even for Former Smokers
Eating well and exercising can make for a longer life, and that holds true for former smokers, too, a new study shows. Researchers found that of nearly 160,000 former smokers, those who exercised, ate healthfully and limited their drinking were less likely to die over the next couple of decades, versus their counterparts with less-healthy… read on > read on >
Less Salt, More Whole Grains: FDA Updates Food Label Definition of ‘Healthy’
Salmon can’t be labeled a “healthy” food under existing federal regulations, because it contains high levels of fat. But sweetened cereals can bear the “healthy” label on their packaging if they tick specific boxes related to individual nutrients — even though they might be loaded with added sugars. These contradictions fly in the face of… read on > read on >
Two Cases Show COVID Virus Mutating Around Standard Treatment Remdesivir
Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports. After lengthy COVID infections, two kidney transplant patients on immune-suppressing drugs to prevent organ rejection developed a mutated version of SARS-CoV-2 resistant to remdesivir, according to researchers at NYU Grossman School of Medicine and… read on > read on >